One of the identified kinases, inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE), a non-canonical I-kappa-B kinase, has been identified as a breast cancer oncogene amplified and overexpressed in more than 30% of breast carcinomas [36]. The gene discussed is IKBKE; the disease is breast cancer.